155 results about "Trioxane" patented technology

The polymer of the present invention is derived from cyclic ether monomers, dioxane, dioxalane or trioxane and contains both pendant Rf fluoro groups as well as polar groups. These polymers have good wetting, or flow, or leveling properties. They can be reacted with other monomers, such as in the preparation of polyesters, and can be used in waxes, polishes and coatings.

A polyacetal resin composition which comprises a polyacetal resin having a trioxane content of 100 ppm or lower (desirably 50 ppm or lower, preferably 10 ppm or lower) and at least one stabilizer selected among an antioxidant, formaldehyde depressant, processing stabilizer, and heat stabilizer. The polyacetal resin may be a polyacetal resin (especially a copolyacetal) whose trioxane content has been reduced by a solvent treatment and / or heat treatment. The polyacetl resin composition may further contain at least one additive selected among a weathering (light) stabilizer, impact modifier, gloss control agent, sliding modifier, colorant, and filler. This polyacetal resin composition can give a molded article significantly reduced in trioxane extraction and / or volatile-organic amount.

In the present invention relates to a novel series of antimalarial 1,2,4-trioxanes analogues of general formula 7,wherein R represents cycloalkyl groups selected from the groups consisting of cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl or aryl groups selected from phenyl, 4-bromophenyl and 4-chlorophenyl, R1 and R2 represent hydrogen, alkyl group selected from methyl, ethyl, propyl and decyl, aryl selected from phenyl or parts of a cyclic systems such as cyclopentane, cyclohexane, substituted cyclohexane, cycloheptane bicyclo(2.2.1)heptane, adamantane and its preparation thereof; several of these novel compounds show promising antimalarial activity against multidrug resistant malaria in mice.

The present invention relates to a method for preparing 1,3,5-trioxane using a distillation tower including a reactor, a distillation section, and an extraction section. Particularly, the present invention relates to a method for preparing 1,3,5-trioxane, which involves utilizing the water phase separated from the stream discharged through the extraction section of the distillation tower in the process for extracting 1,3,5-trioxane.

In only two steps and in 65% overall yield, natural trioxane artemisinin (I) was converted on gram scale into C-10-carba trioxane dimer (3). This new, very stable dimer was then transformed easily in one additional step into four different dimers (4-7). Alcohol and diol dimers (4 and 5) and ketone dimer (7) are 10 times more antimalarially potent in vitro than artemisinin (I), and alcohol and diol dimers (4 and 5) are strongly inhibitory but not cytotoxic toward several human cancer cell lines. Water-soluble carboxylic acid derivatives (8a-10c and 12) were easily prepared from dimers (4-6); they are thermally stable even at 60° C. for 24 hours, are more orally efficacious as antimalarials than either artelinic acid or sodium artesunate, and have potent and selective anticancer activities. Further derivitization of the alcohol dimers (4 and 17), diol dimer (5) and ketone (7) has produced a number of analogs also antimalarially active in vitro at sub-nanomolar concentrations (most notably: pyridine N-oxides (13, 15, 18, 23, 24 and 25), phosphoric acid triesters (26 and 27), sulfonamide (40) and cyclic carbonate (41)). In addition, dimers (13 and 19) are more efficacious (when administered both orally and i.v.) and less toxic (when administered intraperitoneally to mice as a single dose) than clinically-used sodium artesunate, thereby giving them a better antimalarial therapeutic index than sodium artesunate.

In one embodiment, the invention relates to a process for producing an acrylate product. The process comprises the step of reacting a reaction mixture comprising an alkanoic acid and an alkylenating agent composition under conditions effective to form a crude acrylate product. The alkylenating agent composition comprises at least 1 wt % of a ring-structured compound comprising at least two oxygen atoms and at least one carbon atom, e.g., trioxane and / or tetraoxane. The process further comprises the step of separating at least a portion of the crude acrylate product to form at least one alkylenating agent stream and at least one purified acrylate product stream comprising acrylate product.